The State of Diversity in Healthcare Marketing: For years, pharma has talked about diversity and inclusion issues in its midst, with some pundits saying the industry was slow to embrace diversity and others claiming that it's ahead of the curve.
AstraZeneca VP, head of U.S. oncology, Olivier Nataf details how being a company lifer impacted his career.
Two touted products in the pipeline reflect three of medical marketing's most profound modern-era challenges.
Meet "the connectors" as four of the best-regarded medical science liaisons and the leader of the MSL Society discuss what they do, how they do it, and why their work is so vital.
MM&M and Publicis Health debut results of their first Diversity Survey, detailing areas where healthcare agencies are progressing with regard to diversity and inclusion. Pharma leaders interviewed by MM&M say there are signs the industry is finally getting it right.
MM&M is honoring 15 of the most-senior women in healthcare along with 20 Women to Watch who are changing the industry.
MM&M is honoring 20 Women to Watch, aspiring healthcare commercial and marketing execs changing the face of the industry.
Read the May 2018 issue in its entirety.
At the Asembia Specialty Pharma summit, speakers described a healthcare ecosystem in which specialty products will represent nearly half of all drug spending.
Four agencies are making a difference by supporting nonprofits, educating and empowering youth, and promoting wellness and sustainability in communities around the world